Gritstone 4+6

This study is testing a new vaccine, known as GRT-R910, to be used as a booster to prevent coronavirus infection (COVID-19)

It is sponsored by Gritstone bio, Inc and is being carried out by a team of researchers at Manchester University NHS Foundation Trust

This study has ended and is currently not accepting new applicants.

Trial ID

  • NCT05148962

Share this study